摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

benzyl(bromomethyl)dimethylsilane | 77861-50-8

中文名称
——
中文别名
——
英文名称
benzyl(bromomethyl)dimethylsilane
英文别名
benzyl-(bromomethyl)-dimethylsilane
benzyl(bromomethyl)dimethylsilane化学式
CAS
77861-50-8
化学式
C10H15BrSi
mdl
——
分子量
243.219
InChiKey
IZXPHLKDORXMKK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    115-118 °C
  • 密度:
    1.191±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.41
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

反应信息

  • 作为反应物:
    描述:
    benzyl(bromomethyl)dimethylsilane乙醚 为溶剂, 生成 hexakis[(dimethyl(benzyl)silyl)methyl]distannoxane
    参考文献:
    名称:
    Synthesis of bulky tris[(dimethyl(alkyl/aryl)silyl)methyl]stannanes as radical based reducing agents
    摘要:
    The synthesis of novel bulky tris[dimethyl(ethyl/benzyl/p-tolyl/alpha-naphthyl)silylmethyl]stannanes (1-4) is described. Alkylation of SnCl4 with Me-2(ethyl/p-tolyl)SiCH2MgBr (10-11) gave mainly the triorganotin chlorides [(Me-2(ethyl/p-tolyl)SiCH2)](3)SnCl 14 and 15, which were isolated by silica gel chromatography. Reduction of 14 and 15 with LiAlH4 in THF gave the corresponding triorganotin hydrides 1 and 2, respectively. [Me-2(benzyl/alpha-naphthyl)SiCH2](3)SnCl 16 and 17, generated by the alkylation of SnCl4 with Me-2(benzyl/alpha-naphthyl) SiCH2MgBr 12 and 13, were inseparable from the minor product [Me-2(benzyl/alpha-naphthyl)SiCH2](2)SnCl2 18 and 19, respectively. Treatment of the mixtures of 16/18 and 17/19 with NaOH furnished the corresponding mixtures of stannoxanes, from which the hexakisdistannoxanes [Me-2(benzyl/alpha-naphthyl)SiCH2](6)Sn2O 20 and 22 were isolated from the minor dialkyltin oxide derivatives [Me-2(benzyl/alpha-naphthyl)SiCH2](2)SnO in good yields. Reduction of 20 and 22 with BH3 in THF gave [Me-2(benzyl/alpha-naphthyl)SiCH2](3)SnH (3 and 4), respectively in good yields. H-1, C-13, Sn-119, Si-29 NMR characteristics of the newly synthesized compounds are included. (C) 2011 Elsevier B. V. All rights reserved.
    DOI:
    10.1016/j.jorganchem.2011.05.011
  • 作为产物:
    描述:
    溴甲基二甲基氯硅烷 、 苄基溴化镁 以 乙醚 为溶剂, 以87%的产率得到benzyl(bromomethyl)dimethylsilane
    参考文献:
    名称:
    Synthesis of bulky tris[(dimethyl(alkyl/aryl)silyl)methyl]stannanes as radical based reducing agents
    摘要:
    The synthesis of novel bulky tris[dimethyl(ethyl/benzyl/p-tolyl/alpha-naphthyl)silylmethyl]stannanes (1-4) is described. Alkylation of SnCl4 with Me-2(ethyl/p-tolyl)SiCH2MgBr (10-11) gave mainly the triorganotin chlorides [(Me-2(ethyl/p-tolyl)SiCH2)](3)SnCl 14 and 15, which were isolated by silica gel chromatography. Reduction of 14 and 15 with LiAlH4 in THF gave the corresponding triorganotin hydrides 1 and 2, respectively. [Me-2(benzyl/alpha-naphthyl)SiCH2](3)SnCl 16 and 17, generated by the alkylation of SnCl4 with Me-2(benzyl/alpha-naphthyl) SiCH2MgBr 12 and 13, were inseparable from the minor product [Me-2(benzyl/alpha-naphthyl)SiCH2](2)SnCl2 18 and 19, respectively. Treatment of the mixtures of 16/18 and 17/19 with NaOH furnished the corresponding mixtures of stannoxanes, from which the hexakisdistannoxanes [Me-2(benzyl/alpha-naphthyl)SiCH2](6)Sn2O 20 and 22 were isolated from the minor dialkyltin oxide derivatives [Me-2(benzyl/alpha-naphthyl)SiCH2](2)SnO in good yields. Reduction of 20 and 22 with BH3 in THF gave [Me-2(benzyl/alpha-naphthyl)SiCH2](3)SnH (3 and 4), respectively in good yields. H-1, C-13, Sn-119, Si-29 NMR characteristics of the newly synthesized compounds are included. (C) 2011 Elsevier B. V. All rights reserved.
    DOI:
    10.1016/j.jorganchem.2011.05.011
点击查看最新优质反应信息

文献信息

  • N-derivatives of 1-deoxy nojirimycin
    申请人:Merrell Dow Pharmaceuticals, Inc.
    公开号:US05252587A1
    公开(公告)日:1993-10-12
    This invention relates to novel N-derivatives of 1-deoxy nojirimycin, to the method for their preparation and to their use in the treatment of diabetes and the use against retro-viruses, particularly in the treatment of acquired immuno-deficiency syndrome (AIDS).
    本发明涉及新的1-去氧诺吉霉素的N-衍生物,其制备方法以及它们在糖尿病治疗和抗逆转录病毒方面的应用,特别是在获得性免疫缺陷综合症(艾滋病)治疗中的应用。
  • Base cleavage of the benzyl−silicon bond in PhCH2SiMe2(CH2)nOH (n = 2 or 3) compounds
    作者:Colin Eaborn、Foad M.S. Mahmoud
    DOI:10.1016/s0022-328x(00)88969-x
    日期:1981.4
  • Synthesis of bulky tris[(dimethyl(alkyl/aryl)silyl)methyl]stannanes as radical based reducing agents
    作者:Abdalla E.A. Hassan、Ahmed F. El-Farargy、Terence N. Mitchell
    DOI:10.1016/j.jorganchem.2011.05.011
    日期:2011.9
    The synthesis of novel bulky tris[dimethyl(ethyl/benzyl/p-tolyl/alpha-naphthyl)silylmethyl]stannanes (1-4) is described. Alkylation of SnCl4 with Me-2(ethyl/p-tolyl)SiCH2MgBr (10-11) gave mainly the triorganotin chlorides [(Me-2(ethyl/p-tolyl)SiCH2)](3)SnCl 14 and 15, which were isolated by silica gel chromatography. Reduction of 14 and 15 with LiAlH4 in THF gave the corresponding triorganotin hydrides 1 and 2, respectively. [Me-2(benzyl/alpha-naphthyl)SiCH2](3)SnCl 16 and 17, generated by the alkylation of SnCl4 with Me-2(benzyl/alpha-naphthyl) SiCH2MgBr 12 and 13, were inseparable from the minor product [Me-2(benzyl/alpha-naphthyl)SiCH2](2)SnCl2 18 and 19, respectively. Treatment of the mixtures of 16/18 and 17/19 with NaOH furnished the corresponding mixtures of stannoxanes, from which the hexakisdistannoxanes [Me-2(benzyl/alpha-naphthyl)SiCH2](6)Sn2O 20 and 22 were isolated from the minor dialkyltin oxide derivatives [Me-2(benzyl/alpha-naphthyl)SiCH2](2)SnO in good yields. Reduction of 20 and 22 with BH3 in THF gave [Me-2(benzyl/alpha-naphthyl)SiCH2](3)SnH (3 and 4), respectively in good yields. H-1, C-13, Sn-119, Si-29 NMR characteristics of the newly synthesized compounds are included. (C) 2011 Elsevier B. V. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐